EUVIMEDEUVIMED entdecken
Crossref

Transglutaminase 2 expression is associated with increased risk of lymph node metastasis and recurrence in papillary thyroid cancer

Yagmur Goksoy Solak, Gulcin Yegen, Semen Onder, Sakin Tekin, Ozlem Soyluk, Nurdan Gul, Refik Tanakol, Ferihan Aral, Ayse Kubat Uzum

Endocrine · 2023

DOI: 10.1007/s12020-023-03427-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrine, 2023. Verfasst von Yagmur Goksoy Solak und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey. yagmurgoksoy@gmail.com. Hauptthemen laut MEDLINE: Thyroid Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Transglutaminase 2 (TG2) is associated with mobilization, invasion, and chemoresistance of tumor cells. We aimed to determine whether the immunohistochemical staining with TG2 antibody differs between metastatic and non-metastatic papillary thyroid cancer patients. METHODS: We included 76 patients with papillary thyroid cancer (72% female, median age 52 (24-81) years, follow-up time 107 (60-216) months). Thirty of them with no metastasis, 30 of them with only lymph node metastasis and 16 patients with distant ± lymph node metastasis. Immunohistochemical staining of TG2 antibody was evaluated in the primary tumor and extra-tumoral tissue. We also divided subjects into two groups according to their primary tumor TG2 staining score (group A, high risk group: ≥3, n = 43; group B, low risk group:

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsHumansFemaleMiddle AgedMaleThyroid Cancer, PapillaryLymphatic MetastasisProtein Glutamine gamma Glutamyltransferase 2ThyroidectomyLymph NodesRisk FactorsRetrospective Studies

Stichwörter der Autor:innen

ImmunohistochemicalLymph node metastasisPapillary thyroid cancerRisk assessmentTransglutaminase 2

Substanzen

Protein Glutamine gamma Glutamyltransferase 2

Autor:innen und Institutionen

  • Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey. yagmurgoksoy@gmail.com.
  • Department of Pathology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
  • Department of Endocrinology and Metabolism, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.

Zitieren

APA

Goksoy Solak, Y., Yegen, G., Onder, S., Tekin, S., Soyluk, O., Gul, N., Tanakol, R., Aral, F., & Kubat Uzum, A. (2023). Transglutaminase 2 expression is associated with increased risk of lymph node metastasis and recurrence in papillary thyroid cancer. Endocrine. https://doi.org/10.1007/s12020-023-03427-2

Vancouver

Goksoy Solak Y, Yegen G, Onder S, Tekin S, Soyluk O, Gul N, et al. Transglutaminase 2 expression is associated with increased risk of lymph node metastasis and recurrence in papillary thyroid cancer. Endocrine. 2023. doi:10.1007/s12020-023-03427-2

BibTeX
@article{GoksoySolak2023,
  author = {Goksoy Solak, Yagmur and Yegen, Gulcin and Onder, Semen and Tekin, Sakin and Soyluk, Ozlem and Gul, Nurdan and Tanakol, Refik and Aral, Ferihan and Kubat Uzum, Ayse},
  title = {Transglutaminase 2 expression is associated with increased risk of lymph node metastasis and recurrence in papillary thyroid cancer},
  journal = {Endocrine},
  year = {2023},
  doi = {10.1007/s12020-023-03427-2}
}
Kostenlos starten →